Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma

Clinical trial NCT00273910 · COMPLETED

Trial details

NCT number: NCT00273910
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

High-Risk Melanoma

Start date: 2006-01-01
Primary completion: 2010-05-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.